Jarrod Longcor, Chief Business Officer at Cellectar Biosciences, Inc. (CLRB), bought 130,436 shares at $1.15 ($150K) on 2020-06-05, disclosed to the SEC on 2020-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.15 | 65,218 | $75K | 50.0% |
| 2 | $1.15 | 65,218 | $75K | 50.0% |
| Total | $1.15 avg | 130,436 | $150K | 100% |
| Filing → |
| CLRB | BUY | 2025-03-12 | $8K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $40K | — | Filing → |
| CLRB | BUY | 2019-03-01 | $200 | — | Filing → |